Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status Current. The shortage was first posted on Apr 10, 2020. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 83634-600-02
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)
- Initial Posting
- Apr 10, 2020
Reason
Discontinuation of the manufacture of the drug